TEAS RF New Application

RIABNI

Amgen Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88182290
Filing Date: 11/05/2018

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88182290
MARK INFORMATION
*MARK RIABNI
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT RIABNI
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Amgen Inc.
*STREET One Amgen Center Drive
*CITY Thousand Oaks
*STATE
(Required for U.S. applicants)
California
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
91320-1799
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations; pharmaceutical preparations for treatment of oncologic, inflammatory and auto-immune diseases and disorders; pharmaceutical preparations for treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the blood, skin, bone marrow, nervous system, immune system and joints; pharmaceutical preparations for treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), pemphigus vulgaris (PV), multiple sclerosis (MS), and stem cell transplantation
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Richard Y. Kim
ATTORNEY DOCKET NUMBER 100114-0820
FIRM NAME McDermott Will & Emery LLP
INTERNAL ADDRESS The McDermott Building
STREET 500 North Capitol Street, N.W.
CITY Washington
STATE District of Columbia
COUNTRY United States
ZIP/POSTAL CODE 20001
PHONE 202-756-8000
FAX 202.756.8087
EMAIL ADDRESS IPDocketWashington@mwe.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY all others
CORRESPONDENCE INFORMATION
NAME Richard Y. Kim
FIRM NAME McDermott Will & Emery LLP
INTERNAL ADDRESS The McDermott Building
STREET 500 North Capitol Street, N.W.
CITY Washington
STATE District of Columbia
COUNTRY United States
ZIP/POSTAL CODE 20001
PHONE 202-756-8000
FAX 202.756.8087
*EMAIL ADDRESS IPDocketWashington@mwe.com; rkim@mwe.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 275
*TOTAL FEE PAID 275
SIGNATURE INFORMATION
SIGNATURE /Stuart L. Watt/
SIGNATORY'S NAME Stuart L. Watt
SIGNATORY'S POSITION Vice President, Law and Intellectual Property Officer
DATE SIGNED 11/05/2018



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88182290
Filing Date: 11/05/2018

To the Commissioner for Trademarks:

MARK: RIABNI (Standard Characters, see mark)
The literal element of the mark consists of RIABNI.
The mark consists of standard characters, without claim to any particular font style, size, or color.

The applicant, Amgen Inc., a corporation of Delaware, having an address of
      One Amgen Center Drive
      Thousand Oaks, California 91320-1799
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Pharmaceutical preparations; pharmaceutical preparations for treatment of oncologic, inflammatory and auto-immune diseases and disorders; pharmaceutical preparations for treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the blood, skin, bone marrow, nervous system, immune system and joints; pharmaceutical preparations for treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), pemphigus vulgaris (PV), multiple sclerosis (MS), and stem cell transplantation
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


The applicant's current Attorney Information:
      Richard Y. Kim and all others of McDermott Will & Emery LLP
      The McDermott Building
      500 North Capitol Street, N.W.
      Washington, District of Columbia 20001
      United States
      202-756-8000(phone)
      202.756.8087(fax)
      IPDocketWashington@mwe.com (authorized)
The attorney docket/reference number is 100114-0820.
The applicant's current Correspondence Information:
      Richard Y. Kim
      McDermott Will & Emery LLP
      The McDermott Building
      500 North Capitol Street, N.W.
      Washington, District of Columbia 20001
      202-756-8000(phone)
      202.756.8087(fax)
      IPDocketWashington@mwe.com;rkim@mwe.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Stuart L. Watt/   Date: 11/05/2018
Signatory's Name: Stuart L. Watt
Signatory's Position: Vice President, Law and Intellectual Property Officer
Payment Sale Number: 88182290
Payment Accounting Date: 11/06/2018

Serial Number: 88182290
Internet Transmission Date: Mon Nov 05 18:40:22 EST 2018
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XXX-20181105184022
489136-88182290-61036e1f99f25b691f08f0a8
e335fac4a5b27b53b331a719b8853f5bbca4543c
1-DA-5988-20181024180947580428

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed